Ashwagandha is generally described as well tolerated, and a growing body of case reports has complicated that picture enough to prompt regulatory attention in several countries.
What has been reported?
Cases of liver injury associated with ashwagandha have been published from several countries including Iceland, the United States and India.
The pattern has often been cholestatic, involving impaired bile flow, with jaundice and itching as prominent features.
Onset has typically been weeks to months after starting, and most reported cases recovered after stopping, though some took months.
What regulatory action has been taken?
Denmark restricted ashwagandha in food supplements following a risk assessment that cited concerns including effects on thyroid and sex hormones and potential effects in pregnancy.
Other European bodies have reviewed the evidence, and the regulatory position varies between countries.
It remains available in the UK, and the case reports are worth knowing about.
How common is it?
Rare relative to how widely the supplement is used, which is genuine context rather than reassurance.
Herbal and dietary supplements as a category account for a meaningful proportion of drug induced liver injury cases in registries, and ashwagandha now appears among them.
What are the warning signs?
- Yellowing of the skin or eyes
- Dark urine or pale stools
- Persistent itching without a rash
- Nausea, vomiting or loss of appetite
- Unexplained fatigue
- Pain in the upper right abdomen
Anyone developing these should stop the supplement and see a GP promptly, mentioning what they have been taking.
Who should avoid it?
People with existing liver disease, those taking other medicines affecting the liver, and anyone who drinks heavily.
Taking multiple herbal supplements simultaneously increases the difficulty of identifying a cause if problems arise.
Does dose matter?
Reported cases have involved a range of doses, and staying within studied amounts of 300 to 600 milligrams of standardised extract is sensible.
Long term safety data is limited, since most trials ran twelve weeks or less.
What should you do?
Tell your GP what you take, know the warning signs, and report suspected reactions through the MHRA Yellow Card scheme.
What is the summary?
A real if uncommon signal that has prompted regulatory action elsewhere. Worth knowing, worth monitoring, and a reason to avoid it entirely if you have liver problems.
This article is general information and not medical advice.
What does cholestatic injury mean?
Impaired flow of bile from the liver, which causes jaundice, itching, dark urine and pale stools rather than the pattern seen with direct liver cell damage.
It typically resolves after the cause is removed, though recovery can take weeks to months.
Are some people more susceptible?
Genetic factors influencing susceptibility to drug induced liver injury have been identified for several substances, and individual variation appears to matter.
This is one reason a supplement can be tolerated by most people and cause serious problems in a few.
What is the summary?
An uncommon but genuine signal that has prompted regulatory action in some countries, with case reports accumulating internationally.
Know the warning signs, avoid it entirely with existing liver disease, and report suspected reactions.
How would it be diagnosed?
Through liver function blood tests alongside exclusion of other causes including viral hepatitis, alcohol and prescribed medicines.
Supplement associated injury is often identified by exclusion, which is why telling clinicians what you take matters so much.
What should you weigh?
The modest evidence for benefit against an uncommon but serious potential harm, which is a different calculation from most supplements.
For anyone with liver risk factors that calculation is straightforward.
What about combining supplements?
Taking several herbal products together makes identifying a cause much harder if problems develop, and may increase the overall burden on the liver.
Introducing one at a time is safer and more informative.
What should you tell a clinician?
The product name, the dose, how long you have been taking it and anything else you take alongside it.
Bringing the packet to an appointment is easier than trying to recall the details.